Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Maxim Integrated Products, Inc.

9.6% sales growth and 39.17% return on equity

Maxim Integrated Products, Inc. designs, develops, manufactures, and markets a range of linear and mixed-signal integrated circuits in the United States, China, rest of Asia, Europe, and internationally.

Maxim Integrated Products, Inc.’s sales growth this year is anticipated to be 13% and 5.2% for next year.

Year-on-year quarterly revenue growth grew by 16.2%, now sitting on 2.28B for the twelve trailing months.

Maxim Integrated Products, Inc.’s sales growth for the next quarter is 9.6%. The company’s growth estimates for the present quarter and the next is 21.4% and 13.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 39.17%.

Volatility

Maxim Integrated Products, Inc.’s last day, last week, and last month’s average volatility was 1.03%, 1.75%, and 0.56%, respectively.

Maxim Integrated Products, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 2.58%, 3.49%, and 2.22%, respectively.

Maxim Integrated Products, Inc.’s Stock Yearly Top and Bottom Value

Maxim Integrated Products, Inc.’s stock is valued at $95.38 at 04:22 EST, under its 52-week high of $96.71 and way above its 52-week low of $41.93.

Maxim Integrated Products, Inc.’s Moving Average

Maxim Integrated Products, Inc.’s worth is way above its 50-day moving average of $86.05 and way higher than its 200-day moving average of $73.54.

2. Mr. Cooper Group Inc.

95.4% sales growth and 28.09% return on equity

Mr. Cooper Group Inc. provides servicing, origination, and transaction-based services related principally to single-family residences in the United States.

Mr. Cooper Group Inc.’s sales growth this year is expected to be 31.9% and 3.4% for next year.

Year-on-year quarterly revenue growth grew by 41.1%, now sitting on 2.52B for the twelve trailing months.

Mr. Cooper Group Inc.’s sales growth for the next quarter is 95.4%. The company’s growth estimates for the ongoing quarter and the next is 130.1% and 83.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.09%.

Volatility

Mr. Cooper Group Inc.’s last day, last week, and last month’s average volatility was 1.89%, 0.04%, and 0.41%, respectively.

Mr. Cooper Group Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 2.41%, 3.41%, and 3.73%, respectively.

Mr. Cooper Group Inc.’s Stock Yearly Top and Bottom Value

Mr. Cooper Group Inc.’s stock is valued at $29.50 at 04:22 EST, under its 52-week high of $31.52 and way higher than its 52-week low of $4.31.

Mr. Cooper Group Inc.’s Moving Average

Mr. Cooper Group Inc.’s value is above its 50-day moving average of $28.80 and way above its 200-day moving average of $21.73.

3. iRobot Corporation

23% sales growth and 21.89% return on equity

iRobot Corporation designs, builds, and sells robots to the consumer market in the United States, Europe, the Middle East, Africa, and internationally.

iRobot Corporation’s sales growth this year is anticipated to be 12.9% and 7.3% for next year.

Year-on-year quarterly revenue growth grew by 42.8%, now sitting on 1.31B for the twelve trailing months.

iRobot Corporation’s sales growth for the next quarter is 23%. The company’s growth estimates for the present quarter and the next is a negative 70% and 75%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.89%.

Volatility

iRobot Corporation’s last day, last week, and last month’s average volatility was a negative 1.25%, a positive 0.93%, and a positive 0.36%, respectively.

iRobot Corporation’s last day, last week, and last month’s high and low average amplitude percentage was 3.57%, 4.66%, and 4.07%, respectively.

iRobot Corporation’s Stock Yearly Top and Bottom Value

iRobot Corporation’s stock is valued at $86.35 at 04:22 EST, way under its 52-week high of $98.55 and way above its 52-week low of $32.79.

iRobot Corporation’s Moving Average

iRobot Corporation’s worth is above its 50-day moving average of $80.31 and higher than its 200-day moving average of $79.43.

4. Halozyme Therapeutics, Inc.

281.6% sales growth and 12.5% return on equity

Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, and internationally.

Halozyme Therapeutics, Inc.’s sales growth this year is expected to be 35.4% and 52.2% for next year.

Year-on-year quarterly revenue growth grew by 41.3%, now sitting on 199.56M for the twelve trailing months.

Halozyme Therapeutics, Inc.’s sales growth for the next quarter is 281.6%. The company’s growth estimates for the present quarter and the next is 316.7% and 1025%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.5%.

Volatility

Halozyme Therapeutics, Inc.’s last day, last week, and last month’s average volatility was a negative 2.96%, a positive 0.41%, and a positive 0.10%, respectively.

Halozyme Therapeutics, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 6.52%, 4.77%, and 4.07%, respectively.

Halozyme Therapeutics, Inc.’s Stock Yearly Top and Bottom Value

Halozyme Therapeutics, Inc.’s stock is valued at $43.57 at 04:22 EST, under its 52-week high of $45.76 and way above its 52-week low of $12.71.

Halozyme Therapeutics, Inc.’s Moving Average

Halozyme Therapeutics, Inc.’s worth is above its 50-day moving average of $41.72 and way above its 200-day moving average of $32.13.

5. Alexion Pharmaceuticals, Inc.

9.5% sales growth and 8.92% return on equity

Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products.

Alexion Pharmaceuticals, Inc.’s sales growth this year is expected to be 20.8% and 9.2% for next year.

Year-on-year quarterly revenue growth grew by 25.8%, now sitting on 5.86B for the twelve trailing months.

Alexion Pharmaceuticals, Inc.’s sales growth for the next quarter is 9.5%. The company’s growth estimates for the present quarter and the next is a negative 5.5% and negative -3.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.92%.

Volatility

Alexion Pharmaceuticals, Inc.’s last day, last week, and last month’s average volatility was 1.03%, 0.14%, and 1.49%, respectively.

Alexion Pharmaceuticals, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 0.85%, 1.22%, and 1.47%, respectively.

Alexion Pharmaceuticals, Inc.’s Stock Yearly Top and Bottom Value

Alexion Pharmaceuticals, Inc.’s stock is valued at $157.35 at 04:22 EST, below its 52-week high of $160.03 and way above its 52-week low of $72.67.

Alexion Pharmaceuticals, Inc.’s Moving Average

Alexion Pharmaceuticals, Inc.’s value is way above its 50-day moving average of $140.79 and way above its 200-day moving average of $119.39.

6. Newmont Mining Corporation

44% sales growth and 10.48% return on equity

Newmont Corporation engages in the production and exploration of gold, copper, silver, zinc, and lead.

Newmont Mining Corporation’s sales growth this year is expected to be 17.9% and 22.8% for next year.

Year-on-year quarterly revenue growth grew by 16.8%, now sitting on 11.08B for the twelve trailing months.

Newmont Mining Corporation’s sales growth for the next quarter is 44%. The company’s growth estimates for the ongoing quarter and the next is 90% and 162.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.48%.

Volatility

Newmont Mining Corporation’s last day, last week, and last month’s average volatility was 2.70%, 0.33%, and 0.15%, respectively.

Newmont Mining Corporation’s last day, last week, and last month’s high and low average amplitude percentage was 3.32%, 2.48%, and 2.41%, respectively.

Newmont Mining Corporation’s Stock Yearly Top and Bottom Value

Newmont Mining Corporation’s stock is valued at $63.52 at 04:22 EST, way under its 52-week high of $72.22 and way above its 52-week low of $33.00.

Newmont Mining Corporation’s Moving Average

Newmont Mining Corporation’s value is higher than its 50-day moving average of $60.99 and above its 200-day moving average of $63.41.

7. Rollins, Inc.

5.7% sales growth and 28.62% return on equity

Rollins, Inc., through its subsidiaries, provides pest and termite control services to residential and commercial customers.

Rollins, Inc.’s sales growth this year is anticipated to be 6.9% and 6.7% for next year.

Year-on-year quarterly revenue growth grew by 4.9%, now sitting on 2.13B for the twelve trailing months.

Rollins, Inc.’s sales growth for the next quarter is 5.7%. The company’s growth estimates for the ongoing quarter and the next is 18.2% and 22.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.62%.

Volatility

Rollins, Inc.’s last day, last week, and last month’s average volatility was 1.57%, 0.87%, and 0.38%, respectively.

Rollins, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 1.77%, 3.13%, and 3.15%, respectively.

Rollins, Inc.’s Stock Yearly Top and Bottom Value

Rollins, Inc.’s stock is valued at $40.80 at 04:22 EST, below its 52-week high of $43.00 and way higher than its 52-week low of $20.48.

Rollins, Inc.’s Moving Average

Rollins, Inc.’s value is above its 50-day moving average of $38.50 and way above its 200-day moving average of $36.38.

LEAVE A REPLY

Please enter your comment!
Please enter your name here